Skip to main content

Closed

QNTM: Quantum BioPharma Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC819.1%

Financially safe

Stretched

Debt / equity1.46×

Interest coverage-11.7×

Current ratio0.63×

Quantum BioPharma Ltd.

QNTMNASDAQ Global Market·USD·Closed

Quantum BioPharma Ltd.

QNTMNASDAQ·USD·Closed

$2.89

+1.76%

$2.89

+$0.05 (1.76%)

52W Range

3thpctl

Volume

0.19×avg

Mkt Cap

18.49MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

3thpctl

Volume

0.19×avg

Market Cap

18.49MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings